Henan Cancer Hospital clinical trials
Listed in the registry as: Government agency.
The registry lists 234 studies whose lead sponsor is Henan Cancer Hospital. 130 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 22, 2026.
Keep track of what changes. Save the Henan Cancer Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesWhere
- China
- 189
Focus areas
Conditions Henan Cancer Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 234. Browse all 234 →
- Serplulimab Combined With Chemotherapy for Early-stage HR+/HER2- Breast CancerRecruitingNCT06860529Phase 2
- Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical StudyNot yet recruitingNCT07888556
- ARX788 in HER2-positive Metastatic Breast Cancer PatientsRecruitingNCT06663748Phase 2
- Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast CancerRecruitingNCT05296577Phase 2
- SHR2554 Combined With Endocrine Therapy in Advanced Breast CancerRecruitingNCT07125950Phase 2
- A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined With Capecitabine in the Treatment of Active Brain Metastasis of TNBCRecruitingNCT06598046Phase 2
- Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain MetastasesRecruitingNCT07100600Phase 2
- Trastuzumab Combined With Retlirafusp Alfa in Treating HER2(Human Epidermal Growth Factor Receptor 2) 2+/3+ Gastric/Gastroesophageal Junction Adenocarcinoma After First-line Systemic Therapy FailureNot yet recruitingNCT07817654Phase 2
- Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With MyelofibrosisRecruitingNCT07802405Phase 1
- Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Immunochemotherapy for Resectable Esophageal Cancer: A Target Trial Emulation StudyNot yet recruitingNCT07778056
- AI-Driven Digital Twin and Drug Simulation for Esophageal CancerNot yet recruitingNCT07757022
- Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant ImmunochemotherapyRecruitingNCT07629817Phase 3
- Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell LymphomaNot yet recruitingNCT07459608Phase 2
- A Multicenter, Open-label, Randomized, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent ChemoradiotherapyRecruitingNCT07559786Phase 2
- Tolerability of Dalpiciclib vs. Abemaciclib/Ribociclib in Early HR+/HER2- Breast CancerNot yet recruitingNCT07706933Not applicable
- Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung CancerNot yet recruitingNCT07702305Phase 1
- Toripalimab Combined With Beat Chemotherapy in the Treatment of Advanced Back-line Small Cell Lung CancerNot yet recruitingNCT07698054Phase 2
- Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted TherapyNot yet recruitingNCT07684950Phase 2
- A Multicenter, Randomized, Open-label, Controlled Study of HAIC Combined With Camrelizumab and Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinoma With High-risk Recurrence FactorsNot yet recruitingNCT07618546Not applicable
- Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction CancerNot yet recruitingNCT07610629Phase 2
- Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung CancerRecruitingNCT07559097Phase 1/2
- A Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast CancerRecruitingNCT07540533Phase 2
- Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast CancerRecruitingNCT05398861Phase 2
- Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain MetastasesRecruitingNCT05769010Phase 2
- CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell LymphomaNot yet recruitingNCT07492407
- Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell LymphomaNot yet recruitingNCT07472621
- A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and PalonosetronNot yet recruitingNCT07442890Not applicable
- Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerNot yet recruitingNCT07416253Phase 2
- Anlotinib in Cross-line Treatment of NSCLC and SCLCNot yet recruitingNCT07400575
- the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With TrilaciclibEnrolling by invitationNCT06370416Phase 2
- Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor ThrombusNot yet recruitingNCT07363512Phase 2
- Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical TrialNot yet recruitingNCT07332221Phase 3
- Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric CancerRecruitingNCT07334431Phase 1/2
- QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast CancerRecruitingNCT06967103Phase 2
- RE002 T Cell Injection for the Treatment of KRAS G12D Mutated Solid TumorsRecruitingNCT06546150Phase 1
- Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBCRecruitingNCT06817525Phase 2
- Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001RecruitingNCT07264569Phase 1/2
- Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast CancerNot yet recruitingNCT07256964Phase 2
- Clinical Study on Using TCR to Predict the Effect of Tislelizumab + Chemotherapy in the First-line Treatment of ES-SCLCRecruitingNCT07244016
- Zanubrutinib Combined With Rituximab in the Treatment for Patients With Marginal Zone LymphomaRecruitingNCT07233720
- Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital PathologyNot yet recruitingNCT07203690
- Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FNRecruitingNCT07187908Phase 2
- Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.Not yet recruitingNCT07136974Phase 2
- A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT07108816Phase 2
- Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ CancerRecruitingNCT06329973Phase 1/2
- Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast CancerRecruitingNCT07057427Phase 3
- Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCNot yet recruitingNCT07047755Phase 2
- Evaluation of the Effectiveness and Safety of Laparoscopic Assisted Mastectomy With Preservation of Nipple and Areola, Immediate One-step Breast Reconstruction With Pectoral Muscle Prosthesis and Patch, and Simultaneous Autologous Fat TransplantationRecruitingNCT07037537Not applicable
- Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort StudyRecruitingNCT07037576
- NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.RecruitingNCT06781281